Certified by Founder Lodge
Arsenal Biosciences, Inc.
United States - South San Francisco , CA
START UP
1 Disclosed Funding Rounds $325,000,000
0 Participating Investments
-
Founded date
2019
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
ArsenalBiosciences, Inc., is a clinical stage programmable cell therapy company focused on the realization of solid tumor cell therapy to defeat cancer. Our discovery engine comprises precise
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| September, 04 ,2024 | Series C | $325,000,000 | |
| September, 05 ,2024 | Series C | Undisclosed Amount |
Hitachi Ventures
nVentures
Rock Springs Capital
Luma Group
Westlake Village BioPartners®
Byers Capital
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
Humand | $66,000,000 | (Feb 24, 2026)
Turgo.ai | $1,000,000 | (Feb 24, 2026)
Solid (AI for Data) | $20,000,000 | (Feb 24, 2026)
Freeform | $67,000,000 | (Feb 24, 2026)
Comeryx | $7,500,000 | (Feb 24, 2026)
